Receipt of Proceeds from Second Tranche Put Option

Summary by AI ^BETAClose X

Roadside Real Estate PLC has received £14 million in cash proceeds from CGV Ventures 1 Ltd following the exercise of a Put Option Agreement for the second tranche of its shareholding in Cambridge Sleep Sciences, which will be used to fund the acquisition of Hoch Group Ltd. The company retains the option to sell its remaining interest in Cambridge Sleep Sciences between September 1, 2027, and September 30, 2027, for up to an additional £20 million.

Disclaimer*

Roadside Real Estate PLC

15 June 2026

Roadside Real Estate PLC

("Roadside", the "Company" or the "Group")

Receipt of Proceeds from Second Tranche of Put Option

Roadside (AIM: ROAD), the UK energy forecourt real estate business, confirms that it has received a further £14 million of cash proceeds from CGV Ventures 1 Ltd following the exercise of the Put Option Agreement relating to the second tranche of its shareholding in Cambridge Sleep Sciences ("CSS"). The proceeds will be used to facilitate completion of the acquisition of Hoch Group Ltd.

The balance of Roadside's interest in CSS can be sold in the period from 1 September 2027 to 30 September 2027 for consideration of up to £20 million following the exercise of the Put Option Agreement in relation to the Company's remaining shareholding in CSS.

Enquiries

Roadside Real Estate PLC

Steve Carson, Chairman

Charles Dickson, Chief Executive Officer

Douglas Benzie, Chief Financial Officer

c/o Montfort

Montfort

Ann-marie Wilkinson

Alex Everett

+44 (0)7730 623815

+44 (0)7780 431533

Cavendish Capital Markets Limited (Nomad & Joint Corporate Broker)

Matt Goode / Seamus Fricker / Elysia Bough (Corporate Finance)

Matt Lewis / Harriet Ward (ECM)

+44 (0) 20 7220 0500

Shore Capital (Joint Corporate Broker)

Ben Canning (Corporate Broking)

Stephane Auton / James Thomas / Harry Davies-Ball (Corporate Advisory)

+44 (0)20 7408 4050

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END